ALNY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $11,438,789.45

Alnylam Pharmaceuticals Insider Trading History Chart

Alnylam Pharmaceuticals Share Price & Price History

^$145.32

▼ -1.4 (-0.95%)

As of 04/17/2024 01:00 AM ET

Days: 30 | 90 | 365

AI “wealth window” is closing soon!

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

Alnylam Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/27/2023	Michael W. Bonney	Director	Sell	30,000	$195.00	$5,850,000.00	16,029
8/7/2023	Pushkal Garg	CMO	Sell	4,166	$183.89	$766,085.74	4,345
8/4/2023	Jeffrey V. Poulton	CFO	Sell	3,460	$185.85	$643,041.00	15,873
8/4/2023	Pushkal Garg	CMO	Sell	3,461	$185.85	$643,226.85	8,511
8/4/2023	Yvonne Greenstreet	CEO	Sell	4,057	$185.85	$753,993.45	35,216
4/27/2023	Akshay Vaishnaw	President	Sell	2,392	$194.59	$465,459.28	17,890
4/27/2023	Jeffrey V. Poulton	CFO	Sell	977	$194.59	$190,114.43	11,706
4/27/2023	Pushkal Garg	CMO	Sell	1,839	$194.59	$357,851.01	6,800
4/27/2023	Tolga Tanguler	EVP	Sell	1,476	$194.59	$287,214.84	1,801
4/27/2023	Yvonne Greenstreet	CEO	Sell	7,615	$194.59	$1,481,802.85	30,332
4/6/2023	Indrani Lall Franchini	EVP	Sell	3,500	$210.00	$735,000.00
3/3/2023	Pushkal Garg	CMO	Sell	18,072	$200.00	$3,614,400.00	4,345
2/2/2023	Indrani Lall Franchini	EVP	Sell	1,675	$226.01	$378,566.75	3,500
8/5/2022	Tolga Tanguler	EVP	Sell	1,841	$218.16	$401,632.56
8/3/2022	Tolga Tanguler	EVP	Sell	1,754	$210.00	$368,340.00	3,629
7/5/2022	Tolga Tanguler	EVP	Sell	1,754	$150.00	$263,100.00	1,754
4/1/2022	Steven M. Paul	Director	Sell	15,000	$170.69	$2,560,350.00	1,000
12/23/2021	Akshay Vaishnaw	Insider	Sell	2,879	$190.93	$549,687.47
11/12/2021	John Maraganore	CEO	Sell	33,978	$171.52	$5,827,906.56
8/13/2021	John Maraganore	CEO	Sell	33,979	$199.78	$6,788,324.62	248,744
8/6/2021	Yvonne Greenstreet	COO	Sell	53,064	$199.00	$10,559,736.00
8/5/2021	Laurie Keating	EVP	Sell	10,000	$188.95	$1,889,500.00	13,008
7/12/2021	Laurie Keating	EVP	Sell	6,812	$178.96	$1,219,075.52	6,944
6/18/2021	Akshay Vaishnaw	Insider	Sell	14,708	$175.00	$2,573,900.00	24,953
6/9/2021	Laurie Keating	EVP	Sell	1,734	$154.00	$267,036.00	5,132
5/13/2021	John Maraganore	CEO	Sell	33,979	$130.78	$4,443,773.62	248,744
4/21/2021	Akshay Vaishnaw	Insider	Sell	2,732	$136.95	$374,147.40	22,908
4/19/2021	Akshay Vaishnaw	Insider	Sell	3,706	$137.67	$510,205.02	22,908

AI “wealth window” is closing soon!

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Alnylam Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/5/2024	First Hawaiian Bank	4,000	$0.60M	0.0%	-96.4%	0.003%
4/5/2024	Los Angeles Capital Management LLC	2,959	$0.44M	0.0%	-82.6%	0.002%
3/22/2024	PNC Financial Services Group Inc.	13,118	$2.51M	0.0%	-16.3%	0.010%
3/11/2024	Vanguard Group Inc.	11,943,895	$2.29B	0.0%	+2.5%	9.483%
3/1/2024	Goldman Sachs Group Inc.	291,368	$55.77M	0.0%	-6.6%	0.231%
2/26/2024	Teachers Retirement System of The State of Kentucky	30,713	$5.88M	0.1%	-40.7%	0.024%
2/21/2024	V Square Quantitative Management LLC	274	$52K	0.0%	N/A	0.000%
2/20/2024	Eventide Asset Management LLC	87,000	$16.65M	0.3%	N/A	0.069%
2/17/2024	FIL Ltd	76,837	$14.71M	0.0%	-14.6%	0.061%
2/16/2024	Public Employees Retirement System of Ohio	55,417	$10.61M	0.0%	+1.4%	0.044%
2/15/2024	Employees Retirement System of Texas	3,761	$0.72M	0.0%	N/A	0.003%
2/15/2024	Palo Alto Investors LP	154,437	$29.56M	2.7%	N/A	0.123%
2/15/2024	Dodge & Cox	3,674,310	$703.30M	0.4%	-1.9%	2.917%
2/15/2024	Systematic Portfolios LLC	1,636	$0.31M	0.9%	N/A	0.001%
2/15/2024	Virtus ETF Advisers LLC	1,749	$0.34M	0.2%	+14.1%	0.001%
2/15/2024	Horizon Kinetics Asset Management LLC	2,880	$0.55M	0.0%	-4.0%	0.002%
2/15/2024	Legal & General Group Plc	930,939	$178.19M	0.0%	+17.1%	0.742%
2/15/2024	Andra AP fonden	35,500	$6.80M	0.4%	+2.9%	0.028%
2/15/2024	Vanguard Group Inc.	11,943,895	$2.29B	0.1%	+2.5%	9.518%
2/15/2024	Voya Investment Management LLC	84,123	$16.10M	0.0%	-45.4%	0.067%
2/15/2024	Vident Advisory LLC	1,869	$0.36M	0.0%	+7.1%	0.001%
2/15/2024	Oracle Alpha Inc.	2,111	$0.40M	0.5%	N/A	0.002%
2/15/2024	Prelude Capital Management LLC	1,656	$0.32M	0.0%	N/A	0.001%
2/15/2024	Price T Rowe Associates Inc. MD	3,483,969	$666.87M	0.1%	-11.2%	2.776%
2/15/2024	Profund Advisors LLC	8,332	$1.60M	0.1%	+14.8%	0.007%
2/15/2024	Fort Sheridan Advisors LLC	1,078	$0.21M	0.0%	N/A	0.001%
2/15/2024	Gilder Gagnon Howe & Co. LLC	587,045	$112.37M	1.5%	-1.3%	0.468%
2/15/2024	Gotham Asset Management LLC	10,809	$2.07M	0.0%	+250.7%	0.009%
2/15/2024	Brandywine Managers LLC	4,348	$0.83M	0.9%	-5.6%	0.003%
2/15/2024	Bridger Management LLC	18,922	$3.62M	1.4%	N/A	0.015%
2/15/2024	Comerica Bank	13,363	$2.56M	0.0%	-0.5%	0.011%
2/14/2024	Pathstone Holdings LLC	2,884	$0.55M	0.0%	N/A	0.002%
2/14/2024	Kestra Advisory Services LLC	1,268	$0.24M	0.0%	N/A	0.001%
2/14/2024	Point72 Asset Management L.P.	85,990	$16.46M	0.0%	N/A	0.069%
2/14/2024	Creative Planning	5,072	$0.97M	0.0%	+23.1%	0.004%
2/14/2024	Ethic Inc.	4,009	$0.77M	0.0%	+9.2%	0.003%
2/14/2024	BOKF NA	5,417	$1.04M	0.0%	-19.4%	0.004%
2/14/2024	Bridgewater Associates LP	1,951	$0.37M	0.0%	+3.4%	0.002%
2/14/2024	Bellevue Group AG	885,318	$169.46M	2.6%	-1.0%	0.705%
2/14/2024	Avoro Capital Advisors LLC	1,111,111	$212.68M	2.9%	+9.9%	0.885%
2/14/2024	Cresset Asset Management LLC	1,616	$0.31M	0.0%	N/A	0.001%
2/14/2024	Humankind Investments LLC	1,270	$0.24M	0.1%	+11.2%	0.001%
2/14/2024	Regal Investment Advisors LLC	2,965	$0.57M	0.0%	+5.8%	0.002%
2/14/2024	Quilter Plc	1,332	$0.26M	0.0%	N/A	0.001%
2/14/2024	Elo Mutual Pension Insurance Co	10,913	$2.09M	0.1%	+4.7%	0.009%
2/14/2024	Shell Asset Management Co.	3,801	$0.73M	0.0%	-21.3%	0.003%
2/14/2024	Seven Eight Capital LP	5,237	$1M	0.1%	N/A	0.004%
2/14/2024	Vestal Point Capital LP	35,000	$6.70M	0.7%	N/A	0.028%
2/14/2024	RTW Investments LP	1,640,559	$314.02M	4.9%	-2.5%	1.307%
2/14/2024	Sectoral Asset Management Inc.	22,640	$4.33M	1.9%	-21.8%	0.018%
2/14/2024	Schroder Investment Management Group	44,475	$8.51M	0.0%	+481.0%	0.035%
2/14/2024	Privium Fund Management B.V.	21,693	$4.23M	1.0%	+8.3%	0.017%
2/13/2024	Envestnet Asset Management Inc.	27,279	$5.22M	0.0%	+11.0%	0.022%
2/13/2024	Northern Trust Corp	764,520	$146.34M	0.0%	-4.2%	0.609%
2/13/2024	Pinebridge Investments L.P.	10,181	$1.95M	0.0%	+38.0%	0.008%
2/13/2024	Cibc World Markets Corp	3,482	$0.67M	0.0%	N/A	0.003%
2/13/2024	Public Employees Retirement Association of Colorado	14,397	$2.76M	0.0%	+107.8%	0.011%
2/13/2024	Oppenheimer & Co. Inc.	4,379	$0.84M	0.0%	-3.1%	0.003%
2/13/2024	Crossmark Global Holdings Inc.	1,066	$0.20M	0.0%	N/A	0.001%
2/13/2024	Tower Research Capital LLC TRC	6,672	$1.28M	0.0%	+31.1%	0.005%
2/13/2024	Capital World Investors	16,174,563	$3.10B	0.6%	-2.1%	12.889%
2/13/2024	Capital Research Global Investors	2,930,079	$560.88M	0.1%	+5.3%	2.335%
2/13/2024	Capital International Sarl	87,357	$16.72M	0.6%	+0.5%	0.070%
2/13/2024	Capital International Ltd. CA	88,385	$16.92M	0.9%	-4.9%	0.070%
2/13/2024	Capital International Investors	3,586,657	$686.64M	0.2%	+15.8%	2.858%
2/13/2024	DCF Advisers LLC	1,300	$0.25M	0.1%	-27.8%	0.001%
2/13/2024	First Trust Advisors LP	306,693	$58.70M	0.1%	+31.4%	0.244%
2/13/2024	Goldman Sachs Group Inc.	291,368	$55.77M	0.0%	-6.6%	0.232%
2/13/2024	Royal London Asset Management Ltd.	308,824	$59.11M	0.2%	+0.7%	0.245%
2/13/2024	CIBC Private Wealth Group LLC	173,701	$33.25M	0.1%	-0.2%	0.138%
2/13/2024	Rafferty Asset Management LLC	52,808	$10.11M	0.0%	+19.6%	0.042%
2/13/2024	Rhenman & Partners Asset Management AB	37,500	$7.18M	0.7%	-16.7%	0.030%
2/13/2024	CIBC Asset Management Inc	4,014	$0.77M	0.0%	-7.1%	0.003%
2/13/2024	NEOS Investment Management LLC	2,989	$0.57M	0.1%	N/A	0.002%
2/13/2024	The Manufacturers Life Insurance Company	340,820	$65.24M	0.0%	-4.2%	0.272%
2/13/2024	Campbell & CO Investment Adviser LLC	23,371	$4.47M	0.4%	N/A	0.019%
2/13/2024	APG Asset Management US Inc.	24,497	$4.69M	0.0%	N/A	0.020%
2/13/2024	California State Teachers Retirement System	191,578	$36.67M	0.1%	+0.7%	0.153%
2/12/2024	Alberta Investment Management Corp	7,175	$1.37M	0.0%	+147.4%	0.006%
2/12/2024	Eagle Asset Management Inc.	262,865	$50.32M	0.3%	+0.1%	0.209%
2/12/2024	Alpha DNA Investment Management LLC	4,720	$0.90M	0.4%	N/A	0.004%
2/12/2024	Brown Brothers Harriman & Co.	402	$77K	0.0%	-37.4%	0.000%
2/12/2024	Bank of Nova Scotia	6,025	$1.15M	0.0%	+104.4%	0.005%
2/12/2024	Treasurer of the State of North Carolina	86,697	$16.60M	0.1%	+0.9%	0.069%
2/12/2024	Weiss Asset Management LP	1,192	$0.23M	0.0%	N/A	0.001%
2/12/2024	Allianz Asset Management GmbH	13,789	$2.64M	0.0%	-4.6%	0.011%
2/12/2024	Stifel Financial Corp	11,658	$2.23M	0.0%	+44.5%	0.009%
2/12/2024	TD Asset Management Inc	466,085	$89.21M	0.1%	-5.9%	0.371%
2/12/2024	Steward Partners Investment Advisory LLC	480	$92K	0.0%	+14.3%	0.000%
2/12/2024	Hsbc Holdings PLC	44,199	$8.47M	0.0%	+25.6%	0.035%
2/9/2024	Intech Investment Management LLC	7,541	$1.44M	0.0%	-32.8%	0.006%
2/9/2024	Nomura Asset Management Co. Ltd.	69,011	$13.21M	0.1%	+1.5%	0.055%
2/9/2024	Nixon Peabody Trust Co.	3,300	$0.63M	0.1%	+120.0%	0.003%
2/9/2024	Oxford Asset Management LLP	3,064	$0.59M	1.1%	N/A	0.002%
2/9/2024	Commerce Bank	4,683	$0.90M	0.0%	+1.7%	0.004%
2/9/2024	Aigen Investment Management LP	24,544	$4.70M	0.8%	N/A	0.020%
2/9/2024	Franklin Resources Inc.	150,928	$28.89M	0.0%	+0.4%	0.120%
2/9/2024	Assetmark Inc.	6,913	$1.32M	0.0%	+19.6%	0.006%
2/9/2024	Trexquant Investment LP	51,397	$9.84M	0.2%	+366.4%	0.041%
2/9/2024	Corient Private Wealth LLC	274,696	$52.58M	0.1%	+0.6%	0.219%

Data available starting January 2016

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $145.32

$145.19

$147.49

50 Day Range

MA: $152.56

$145.32

$170.03

52 Week Range

Now: $145.32

$143.52

$218.88

Volume

601,282 shs

Average Volume

803,866 shs

Market Capitalization

$18.30 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.39

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?: Alnylam Pharmaceuticals' top insider investors include:
Yvonne Greenstreet (CEO)
Akshay Vaishnaw (President)
Michael W Bonney (Director)
Jeffrey V Poulton (CFO)
Pushkal Garg (CMO)
Tolga Tanguler (EVP)
Indrani Lall Franchini (EVP)
Learn More about top insider investors at Alnylam Pharmaceuticals.
Who are the major institutional investors of Alnylam Pharmaceuticals?: Alnylam Pharmaceuticals' top institutional shareholders include:
Portman Square Capital LLP — 0.00%
First Hawaiian Bank — 0.00%
Los Angeles Capital Management LLC — 0.00%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.
Which major investors are selling Alnylam Pharmaceuticals stock?: In the last quarter, ALNY stock was sold by these institutional investors:
First Hawaiian Bank
Los Angeles Capital Management LLC
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
Yvonne Greenstreet (CEO)
Akshay Vaishnaw (President)
Michael W Bonney (Director)
Jeffrey V Poulton (CFO)
Pushkal Garg (CMO)
Tolga Tanguler (EVP)
Learn More investors selling Alnylam Pharmaceuticals stock.
Which major investors are buying Alnylam Pharmaceuticals stock?: In the previous quarter, ALNY stock was acquired by institutional investors including:
Portman Square Capital LLP